Company Spotlight features video, webcasts, presentations and annual reports for more than 30,000 companies. Sign up to promote your company. ×

Pharmaceutical Preparations CA, United States
Nasdaq: ANTH
Anthera Pharmaceuticals, Inc. is a biopharmaceutical company, which is focused on developing and commercializing products to treat serious diseases associated with inflammation, including cardiovascular and autoimmune diseases. The company's primary product candidate, blisibimod, targets elevated levels of B-cell activating factor, or BAFF. Its other product candidate includes varespladib and varespladib sodium, which provides treatment for the patients who have acute coronary syndrome and acute chest syndrome associated with sickle cell disease. Anthera Pharmaceuticals was founded by Paul F. Truex on September 9, 2004 and is headquartered in Hayward, CA.
Similar to: Columbia Laboratories, Inc., Hutchison China MediTech Ltd., NPS Pharmaceuticals, Inc.
London, Guernsey , GG
**Objective of Aberdeen Private Equity Fund** The investment objective of the Company is to generate long-term capital gains. … Learn more →

Bedminster, NJ, US
NPS Pharmaceuticals, Inc. is a biopharmaceutical company focused on discovering, developing and commercializing small molecule drugs… Learn more →

Hong Kong, HK
Hutchison China MediTech Ltd. is a holding company, which engages in the manufacture, distribution, and sale of traditional Chinese… Learn more →

Livingston, NJ, US
Columbia Laboratories, Inc. develops, manufactures and sells pharmaceutical products. Its pharmaceutical products include CRINONE… Learn more →